Cite
MLA Citation
Xiaochuan Yang et al.. “Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features.” Leukemia research reports, vol. 12, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100098052774.0x000010